UBS AG - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 33 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS AG ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q3 2014$4,000
-42.9%
996
-5.2%
0.00%
Q2 2014$7,000
-98.5%
1,051
-97.1%
0.00%
Q1 2014$460,000
+6471.4%
35,858
+3789.2%
0.00%
Q4 2013$7,0009220.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q3 2014
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 2,623,533$22,851,0006.45%
Avoro Capital Advisors LLC 1,146,579$9,987,0003.44%
Cormorant Asset Management, LP 2,095,334$18,250,0002.18%
Healthcare Value Capital, LLC 50,000$436,0000.72%
CAPITAL MANAGEMENT ASSOCIATES /NY/ 20,000$174,0000.25%
SABBY MANAGEMENT, LLC 300,000$2,613,0000.14%
STRATEGIC INVESTMENT MANAGEMENT, LLC 20,398$177,0000.10%
Granite Investment Partners, LLC 89,622$781,0000.07%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 54,634$476,0000.06%
Trexquant Investment LP 67,929$592,0000.05%
View complete list of SORRENTO THERAPEUTICS INC shareholders